A REVIEW OF THE PHARMACOLOGICAL PROPERTIES OF URSOLIC ACID

  • Bharat Vashistha Research Scholar, Department of Pharmacy Maharishi Arvind University, Jaipur
  • Manish Jaimini Professor & HOD Department of Pharmacy, Maharishi Arvind University, Jaipur
DOI: https://doi.org/10.61280/tjpls.v6i6.112

Keywords:

Ursolic acid, Apoptosis, Antioxidant, Antimicrobial, Hepatoprotective, Immunomodulatory, Chemopreventive, Cardioprotective, Antihyperlipidemic, Hypoglycemic , Antimetastasis

Abstract

Plants are known to produce a variety of bioactive metabolites which are being used to cure various life threatening and chronic diseases. The molecular mechanism of action of such bioactive molecules may open up new avenues for the scientific community to develop or improve novel therapeutic approaches to tackle dreadful diseases such as cancer, cardiovascular and neurodegenerative disorders etc. Ursolic acid (UA) is one among the categories of such plant-based therapeutic metabolites having multiple intracellular and extracellular targets that play role in apoptosis, metastasis, angiogenesis and inflammatory processes. Ursolic acid (UA) is a pentacyclic triterpenoid widely found in herbs, leaves, flowers and fruits. Moreover, the synthetic derivatives of UA have also been seen to be involved in a range of pharmacological applications, the great interest in this bioactive compound is related to the beneficial effects in human health due to antioxidant, antimicrobial, anti-inflammatory, hepatoprotective, immunomodulatory, anti-tumor, chemopreventive, cardioprotective, antihyperlipidemic and hypoglycemic activities, and others. UA may augment the resistance of the skin barrier to irritants, prevent dry skin and could be suitable to develop antiaging products. Evidences suggest that UA could be used as a potential candidate to develop a comprehensive competent strategy towards the treatment and prevention of health disorders. The review article herein describes the possible therapeutic effects of UA along with putative mechanism of action.

Downloads

Download data is not yet available.

References

A. M. Mancha-Ramirez and T. J. Slaga, “Ursolic acid and chronic disease: an overview of UA’s effects on prevention and treatment of obesity and cancer,” Advances in Experimental Medicine and Biology, vol. 928, pp. 75–96, 2016.

A. M. Ramírez-Rodríguez, M. González-Ortiz, E. Martínez- Abundis, and N. Acuña Ortega, “Effect of ursolic acid on metabolic syndrome, insulin sensitivity, and inflammation,” Journal of Medicinal Food, vol. 20, no. 9, pp. 882–886, 2017.

Abe, F., Yamauchi, T., Nagao, T., Kinjo, J., Okabe, H., Higo, H., & Akahane, H. (2002). Ursolic acid as a trypanocidal constituent in rosemary. Biological, & Pharmaceutical Bulletin, 25(11), 1485–1487.

Aguirre-Crespo, F., Vergara-Galicia, J., Villalobos-Molina, R., López-Guerrero, J. J., Navarrete-Vázquez, G., & Estrada-Soto, S. (2006). Ursolic acid mediates the vasorelaxant activity of Lepechinia caulescens via NO release in isolated rat thoracic aorta. Life Sciences, 79, 1062–1068.

Akbarsha, M. A., Palanisamy, M., Murugaian, P., & Lakshmi Latha, P. N. (1998). Ursolic acid generates symplasts in rat spermatogenic clones. Phytotherapy Research, 12(1), 32–36.

Andersson, D., Liu, J. J., Nilsson, A., & Duan, R. D. (2003). Ursolic acid inhibits proliferation and stimulates apoptosis in HT29 cells following activation of alkaline sphingomyelinase. Anticancer Research, 23(4), 3317–3322.

Awad, R., Muhammad, A., Durst, T., Trudeau, V. L., & Arnason, J. T. (2009). Bioassayguided fractionation of lemon balm (Melissa officinalis L.) using an in vitro measure of GABA transaminase activity. Phytotherapy Research, 23(8), 1075–1081.

Balanehru, S., & Nagarajan, B. (1991). Protective effect of oleanolic and ursolic acid against lipid peroxidation. Biochemistry International, 24, 981–990.

Banno, N., Akihisa, T., Tokuda, H., Yasukawa, K., Higashihara, H., Ukiya, M., Nishino, H. (2004). Triterpene acids from the leaves of Perilla frutescens and their anti-inflammatory and antitumor-promoting effects. Bioscience, Biotechnology and Biochemistry, 68(1), 85–90.

Baricevic, D., Sosa, S., Della Loggia, R., Tubaro, A., Simonovska, B., Krasna, A., & Zupancic, A. (2001). Topical anti-inflammatory activity of Salvia officinalis L. leaves: The relevance of ursolic acid. Journal of Ethnopharmacology, 75, 125–132.

Both, D. M., Goodtzova, K., Yarosh, D. B., & Brown, D. A. (2002). Liposome-encapsulated ursolic acid increases ceramides and collagen in human skin cells. Archives of Dermatological Research, 293(11), 569–575.

C. K. Katashima, V. R. Silva, T. L. Gomes, C. Pichard, and G. D. Pimentel, “Ursolic acid and mechanisms of actions on adipose and muscle tissue: a systematic review,” Obesity Reviews, vol. 18, no. 6, pp. 700–711, 2017.

C. Zhang, C. Wang, W. Li et al., “Pharmacokinetics and Pharmacodynamics of the triterpenoid ursolic acid in regulating the antioxidant, anti-inflammatory, and epigenetic gene responses in rat leukocytes,” Molecular Pharmaceutics, vol. 14, no. 11, pp. 3709–3717, 2017.

Cargnin, S. T., & Gnoatto, S. B. (2017). Ursolic acid from apple pomace and traditional plants: A valuable triterpenoid with functional properties. Food Chemistry, 220, 477–489.

Chen, H., Gao, Y., Wang, A., Zhou, X., Zheng, Y., & Zhou, J. (2015). Evolution in medicinal chemistry of ursolic acid derivatives as anticancer agents. European Journal of Medicinal Chemistry, 92, 648–655.

Chen, S. R., Chen, X. P., Lu, J. J., Wang, Y., & Wang, Y. T. (2015). Potent natural products and herbal medicines for treating liver fibrosis. Chinese Medicine (United Kingdom), 10(1) (Article number 7).

Chen, Y., Liu, J., Yang, X., Zhao, X., & Xu, H. (2005). Oleanolic acid nanosuspensions: Preparation, in-vitro characterization and enhanced hepatoprotective effect. Journal of Pharmacy and Pharmacology, 57, 259–264.

Close, G. L., Hamilton, D. L., Philp, A., Burke, L. M., & Morton, J. P. (2016). New strategies in sport nutrition to increase exercise performance. Free Radical Biology and Medicine, 98, 144–158.

Colla, A. R., Rosa, J. M., Cunha, M. P., & Rodrigues, A. L. (2015). Anxiolytic-like effects of ursolic acid in mice. European Journal of Pharmacoly, 758, 171–176.

Collins, M. A., & Charles, H. P. (1987). Antimicrobial activity of carnosol and ursolic acid: two anti-oxidant constituents of Rosmarinus officinalis L. Food Microbiology, 4(4), 311–315.

Croft KD, Yamashita Y, O’Donoghue H, Shirasaya D, Ward NC, Ashida H. Screening plant derived dietary phenolic compounds for bioactivity related to cardiovascular disease. Fitoterapia. 2017. doi: 10.1016/j.fitote.2017.12.002. [Epub ahead of print]

Cui, T., Li, J. Z., Kayahara, H., Ma, L., Wu, L. X., & Nakamura, K. (2006). Quantification of the polyphenols and triterpene acids in Chinese hawthorn fruit by high-performance liquid chromatography. Journal of Agricultural and Food Chemistry, 54(13), 4574–4581.

D. Kashyap, A. Sharma, H. S. Tuli, S. Punia, and A. K. Sharma, “Ursolic acid and oleanolic acid: pentacyclic terpenoids with promising anti-inflammatory activities,” Recent Patents on Inflammation & Allergy Drug Discovery, vol. 10, no. 1, pp. 21–33, 2016.

D. Li, D. Ren, Y. Luo, and X. Yang, “Protective effects of ursolic acid against hepatotoxicity and endothelial dysfunction in mice with chronic high choline diet consumption,” Chemico- Biological Interactions, vol. 258, pp. 102–107, 2016.

D. Y. Seo, S. R. Lee, J. W. Heo et al., “Ursolic acid in health and disease,” The Korean Journal of Physiology & Pharmacology, vol. 22, no. 3, pp. 235–248, 2018.

Da Silva Ferreira, D., Esperandim, V. R., Marçal, M. G., dos Reis Neres, N. B., Cunha, N. L., Silva, M. L. A., & Cunha, W. R. (2013). Natural products and Chagas' disease: The action of triterpenes acids isolated from Miconia species. Universitas Scientiarum, 18(3), 243–256.

De Almeida, M. M., Bou-Chacra, N. A., De Castro Lima, C. R. R., Do Rosário Matos, J., Filho, E. M., Mercuri, L. P., ... Velasco, M. V. R. (2014). Characterization and evaluation of free and nanostructured ursolic acid incorporated in cosmetic formulation using thermal analysis. Journal of Thermal Analysis and Calorimetry, 115(3), 2401–2406.

De Freitas Junior LM, de Almeida EB Jr. Medicinal plants for the treatment of obesity: ethnopharmacological approach and chemical and biological studies. Am J Transl Res. 2017;9:2050-2064.

Deane, C. S., Wilkinson, D. J., Phillips, B. E., Smith, K., Etheridge, T., & Atherton, P. J. (2017).“Nutraceuticals” in relation to human skeletal muscle and exercise. American Journal of Physiology - Endocrinology and Metabolism, 321(4), E282–E299.

Deepak, M., & Handa, S. S. (2000). Antiinflammatory activity and chemical composition of extracts of Verbena officinalis. Phytotherapy Research, 14(6), 463–465.

Diarra M, El Ouahabi H, Bouxid H, Boujraf S, Khabbal Y, Ajdi F. Medicinal plants in type 2 diabetes: therapeutic and economical aspects. Int J Prev Med. 2016;7:56.

Do Nascimento, P. G. G., Lemos, T. L. G., Bizerra, A. M. C., Arriaga, A. M. C., Ferreira, D. A., Santiago, G. M. P., ... Costa, J. G. M. (2014). Antibacterial and antioxidant activities of ursolic acid and derivatives. Molecules, 19(1), 1317–1327.

Domingues, R. M. A., Patinha, D. J. S., Sousa, G. D. A., Villaverde, J. J., Silva, C. M., Freire, C. S. R., Neto, C. P. (2011). Eucalyptus biomass residues from agro-forest and pulping industries as sources of high-value triterpenic compounds. Cellulose Chemistry and Technology, 45(7–8), 475–481.

Dong, H., Yang, X., Xie, J., Xiang, L., Li, Y., Ou, M., ... Jia, L. (2015). UP12, a novel ursolic acid derivative with potential for targeting multiple signaling pathways in hepatocellular carcinoma. Biochemical Pharmacology, 93(2), 151–162.

E. M. Wang, Q. L. Fan, Y. Yue, and L. Xu, “Ursolic acid attenuates high glucose-mediated mesangial cell injury by inhibiting the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) signaling pathway,” Medical Science Monitor, vol. 24, pp. 846–854, 2018.

Farina, C., Pinza, M., & Pifferi, G. (1999). Synthesis and anti-ulcer activity of new derivatives of glycyrrhetic, oleanolic and ursolic acids. Pharmacology, 53(1998), 22–32.

Farwick, M., Kohler, T., Schild, J., Mentel, M., Maczkiewitz, U., Pagani, V., ... Gauglitz, G. G. (2014). Pentacyclic triterpenes from Terminalia arjuna show multiple benefits on aged and dry skin. Skin Pharmacology and Physiology, 27(2), 71–81.

Fernández-Hernández, A., Martínez, A., Rivas, F., García-Mesa, J. A., & Parra, A. (2015). Effect of the solvent and the sample preparation on the determination of triterpenes compounds in two-phase olive-mill-waste samples. Journal of Agricultural and Food Chemistry, 63(17), 4269–4275.

Fu, L., Zhang, S., Li, N., Wang, J., Zhao, M., Sakai, J., ... Ando, M. (2005). Three new triterpenes from Nerium oleander and biological activity of the isolated compounds. Journal of Natural Products, 68, 198–206.

Furtado, R. A., Rodrigues, E. P., Araújo, F. R. R., Oliveira, W. L., Furtado, M. A., Castro, M. B., Tavares, D. C. (2008). Ursolic acid and oleanolic acid suppress preneoplastic lesions induced by 1,2-dimethylhydrazine in rat colon. Toxicologic Pathology, 36, 576–580.

García-Morales, G., Huerta-Reyes, M., González-Cortazar, M., Zamilpa, A., Jiménez- Ferrer, E., Silva-García, R., Aguilar-Rojas, A. (2015). Anti-inflammatory, antioxidant and anti-acetylcholinesterase activities of Bouvardia ternifolia: potential implications in Alzheimer's disease. Archives of Pharmacal Research, 38(7), 1369–1379.

Gilabert, M., Marcinkevicius, K., Andújar, S., Schiavone, M., Arena, M. E., & Bardón, A. (2015). Sesqui- and triterpenoids from the liverwort Lepidozia chordulifera inhibitors of bacterial biofilm and elastase activity of human pathogenic bacteria. Phytomedicine, 22(1), 77–85.

Guinda, Á., Rada, M., Delgado, T., & Castellano, J. M. (2011). Pentacyclic triterpenic acids from Argania spinosa. European Journal of Lipid Science and Technology, 113(2), 231–237.

Guinda, Á., Rada, M., Delgado, T., Gutiérrez-Adánez, P., & Castellano, J. M. (2010). Pentacyclic triterpenoids from olive fruit and leaf. Journal of Agricultural and Food Chemistry, 58(17), 9685–9691.

Guo, S., Duan, J. A., Qian, D., Tang, Y., Wu, D., Su, S., Zhao, Y. (2015). Content variations of triterpenic acid, nucleoside, nucleobase, and sugar in jujube (Ziziphus jujuba) fruit during ripening. Food Chemistry, 167, 468–474.

H. C. Huang, C. Y. Huang, S. Y. Lin-Shiau, and J. K. Lin, “Ursolic acid inhibits IL‐1β or TNF‐α‐induced C6 glioma invasion through suppressing the association ZIP/p62 with PKC‐ζ and down regulating the MMP‐9 expression,” Molecular Carcinogenesis, vol. 48, no. 6, pp. 517–531, 2009.

H. L. Xu, X. T. Wang, Y. Cheng et al., “Ursolic acid improves diabetic nephropathy via suppression of oxidative stress and inflammation in streptozotocin-induced rats,” Biomedicine & Pharmacotherapy, vol. 105, pp. 915–921, 2018.

H.S. Tuli, A.K. Sharma, S.S. Sandhu, D. Kashyap, Cordycepin: A bioactive metabolite with therapeutic potential, Life Sci. 93 (2013) 863–869. doi:10.1016/j.lfs.2013.09.030.

Han, S. K., Kim, Y. G., Kang, H. C., Huh, J. R., Kim, J. Y., Baek, N. I., Lee, D. G. (2014). Oleanolic acid from Fragaria ananassa calyx leads to inhibition of alpha-MSH-induced melanogenesis in B16-F10 melanoma cells. Journal of the Korean Society for Applied Biological Chemistry, 57(6), 735–742.

He, X. J., & Liu, R. H. (2007). Triterpenoids isolated from apple peels have potent antiproliferative activity and may be partially responsible for apple's anticancer activity. Journal of Agricultural and Food Chemistry, 55(11), 4366–4370.

Hsu, H. Y., Yang, J. J., & Lin, C. C. (1997). Effects of oleanolic acid and ursolic acid on inhibiting tumor growth and enhancing the recovery of hematopoietic system postirradiation in mice. Cancer Letters, 111(1–2), 7–13.

Huang, M. T., Ho, C. T., Wang, Z. Y., Ferraro, T., Lou, Y. R., Stauber, K., Conney, A. H. (1994). Inhinition of skin tumorigenesis by Rosemary and its constituents carnosol and ursolic acid. Cancer Research, 54(3), 701–708.

J. Iqbal, B. A. Abbasi, R. Ahmad et al., “Ursolic acid a promising candidate in the therapeutics of breast cancer: current status and future implications,” Biomedicine & Pharmacotherapy, vol. 108, pp. 752–756, 2018.

J. Li, N. Li, S. Yan et al., “Ursolic acid alleviates inflammation and against diabetes-induced nephropathy through TLR4- mediated inflammatory pathway,” Molecular Medicine Reports, vol. 18, no. 5, pp. 4675–4681, 2018.

J. Peng, X. Ren, T. Lan, Y. Chen, Z. Shao, and C. Yang, “Renoprotective effects of ursolic acid on ischemia/reperfusioninduced acute kidney injury through oxidative stress, inflammation and the inhibition of STAT3 and NF-κB activities,” Molecular Medicine Reports, vol. 14, no. 4, pp. 3397–3402, 2016.

J. Q. Ma, J. Ding, L. Zhang, and C. M. Liu, “Protective effects of ursolic acid in an experimental model of liver fibrosis through Nrf2/ARE pathway,” Clinics and Research in Hepatology and Gastroenterology, vol. 39, no. 2, pp. 188–197, 2015.

J. Q. Ma, J. Ding, L. Zhang, and C. M. Liu, “Ursolic acid protects mouse liver against CCl4-induced oxidative stress and inflammation by the MAPK/NF-κB pathway,” Environmental Toxicology and Pharmacology, vol. 37, no. 3, pp. 975– 983, 2014.

J. Q. Ma, J. Ding, Z. H. Xiao, and C. M. Liu, “Ursolic acid ameliorates carbon tetrachloride-induced oxidative DNA damage and inflammation in mouse kidney by inhibiting the STAT3 and NF-κB activities,” International Immunopharmacology, vol. 21, no. 2, pp. 389–395, 2014.

J. S. Li, W. J. Wang, Y. Sun, Y. H. Zhang, and L. Zheng, “Ursolic acid inhibits the development of nonalcoholic fatty liver disease by attenuating endoplasmic reticulum stress,” Food & Function, vol. 6, no. 5, pp. 1643–1651, 2015.

Jäger, S., Trojan, H., Kopp, T., Laszczyk, M. N., & Scheffler, A. (2009). Pentacyclic triterpenes distribution in various plants - Rich sources for a new group of multi-potent plant extracts. Molecules, 14(6), 2016–2031.

Jang, S. M., Yee, S. T., Choi, J., Choi, M. S., Do, G. M., Jeon, S. M., ... Lee, M. K. (2009). Ursolic acid enhances the cellular immune system and pancreatic beta-cell function in streptozotocin-induced diabetic mice fed a high-fat diet. International Immunopharmacology, 9(1), 113–119.

Jayaprakasam, B., Olson, L. K., Schutzki, R. E., Tai, M. H., & Nair, M. G. (2006). Amelioration of obesity and glucose intolerance in high-fat-fed C57BL/6 mice by anthocyanins and ursolic acid in Cornelian cherry (Cornus mas). Journal of Agricultural Food Chemistry, 54, 243–248.

Jiang T, Wang XQ, Ding C, Du XL. Genistein attenuates isofluraneinduced neurotoxicity and improves impaired spatial learning and memory by regulating cAMP/CREB and BDNF-TrkB-PI3K/Akt signaling. Korean J Physiol Pharmacol. 2017;21:579-589.

Jin, H., Pi, J., Yang, F., Wu, C., Cheng, X., Bai, H., Chen, Z. W. (2016). Ursolic acidloaded chitosan nanoparticles induce potent anti-angiogenesis in tumor. Applied Microbiology and Biotechnology, 100(15), 6643–6652.

Jin, Y. R., Jin, J. L., Li, C. H., Piao, X. X., & Jin, N. G. (2012). Ursolic acid enhances mouse liver regeneration after partial hepatectomy. Pharmaceutical Biology, 50, 523–528.

Kadioglu, O., & Efferth, T. (2015). Pharmacogenomic characterization of cytotoxic compounds from Salvia officinalis in cancer cells. Journal of Natural Products, 78(4), 762–775.

Kalogeropoulos, N., Yanni, A. E., Koutrotsios, G., & Aloupi, M. (2013). Bioactive microconstituents and antioxidant properties of wild edible mushrooms from the island of Lesvos, Greece. Food and Chemical Toxicology, 55, 378–385.

Kashyap, D., Tuli, H. S., & Sharma, A. K. (2016). Ursolic acid (UA): A metabolite with promising therapeutic potential. Life Sciences, 146, 201–213.

Katashima CK, Silva VR, Gomes TL, Pichard C, Pimentel GD. Ursolic acid and mechanisms of actions on adipose and muscle tissue: a systematic review. Obes Rev. 2017;18:700-711.

Kazmi, I., Afzal, M., Rahman, S., Iqbal, M., Imam, F., & Anwar, F. (2013). Antiobesity potential of ursolic acid stearoyl glucoside by inhibiting pancreatic lipase. European Journal of Pharmacology, 709(1–3), 28–36.

Kim, E. S., & Moon, A. (2015). Ursolic acid inhibits the invasive phenotype of SNU-484 human gastric cancer cells. Oncology Letters, 9(2), 897–902.

Kim, M. H., Kim, J. N., Han, S. N., & Kim, H. K. (2015). Ursolic acid isolated from guava leaves inhibits inflammatory mediators and reactive oxygen species in LPS-stimulated macrophages. Immunopharmacology and Immunotoxicology, 37(3), 228–235.

Kondo, M., MacKinnon, S. L., Craft, C. C., Matchett, M. D., Hurta, R. A. R., & Neto, C. C. (2011). Ursolic acid and its esters: Occurrence in cranberries and other Vaccinium fruit and effects on matrix metalloproteinase activity in DU145 prostate tumor cells. Journal of the Science of Food and Agriculture, 91(5), 789–796.

Kosuge, T., Yokota, M., Sugiyama, K., Yamazawa, H., & Yamamoto, T. (1985). Studies on bioactive substances in crude drugs used for arthritic diseases in traditional Chinese medicine. III. Isolation and identification of anti-inflammatory and analgesic principles from the whole herb of Pyrola rotundifolia L. Chemical and Pharmaceutical Bulletin, 33(12), 5355–5357.

Kowalski, R. (2007). Studies of selected plant raw materials as alternative sources of triterpenes of oleanolic and ursolic acid types. Journal of Agricultural and Food Chemistry, 55(3), 656–662.

Kunkel SD, Suneja M, Ebert SM, Bongers KS, Fox DK, Malmberg SE, Alipour F, Shields RK, Adams CM. mRNA expression signatures of human skeletal muscle atrophy identify a natural compound that increases muscle mass. Cell Metab. 2011;13:627-638.

Kunkel, S. D., Elmore, C. J., Bongers, K. S., Ebert, S. M., Fox, D. K., Dyle, M. C., Adams, C. M. (2012). Ursolic acid increases skeletal muscle and brown fat and decreases dietinduced obesity, glucose intolerance and fatty liver disease. PLoS ONE, 7(6) (Article number e39332).

Kunkel, S. D., Suneja, M., Ebert, S. M., Bongers, K. S., Fox, D. K., Malmberg, S. E., Adams, C. M. (2011). mRNA expression signatures of human skeletal muscle atrophy identify a natural compound that increases muscle mass. Cell Metabolism, 13, 627–638.

L. Lin, Y. Yin, G. Hou, D. Han, J. Kang, and Q. Wang, “Ursolic acid attenuates cigarette smoke-induced emphysema in rats by regulating PERK and Nrf2 pathways,” Pulmonary Pharmacology & Therapeutics, vol. 44, pp. 111–121, 2017.

Lauthier, F., Taillet, L., Trouillas, P., Delage, C., & Simon, A. (2000). Ursolic acid triggers calcium-dependent apoptosis in human Daudi cells. Anticancer Drugs, 11, 737–745.

Leake I. Liver: plant sterols have a role in liver injury associated with parenteral nutrition. Nat Rev Gastroenterol Hepatol. 2013;10:693.

Lee, H. K., Nam, G. W., Kim, S. H., & Lee, S. H. (2006). Phytocomponents of triterpenoids, oleanolic acid and ursolic acid, regulated differently the processing of epidermal keratinocytes via PPAR-alpha pathway. Experimental Dermatology, 15(1), 66–73.

Lee, Y. H., Wang, E. X., Kumar, N., & Glickman, R. D. (2014). Ursolic acid differentially modulates apoptosis in skin melanoma and retinal pigment epithelial cells exposed to UV–VIS broadband radiation. Apoptosis, 19(5), 816–828.

Li, K., Nazierbieke, W., Qiao, J., Li, H., Yao, F. C., & Borrathy-Bay, E. (2011). Quantitative determination of ursolic acid and luteolin in Paulownia fortune produced from different places by HPLC. Pharmaceutical Biotechnology, 18(3), 251–255.

Li, S., Liao, X., Meng, F., Wang, Y., Sun, Z., Guo, F., Sun, C. (2014). Therapeutic role of ursolic acid on ameliorating hepatic steatosis and improving metabolic disorders in high-fat diet-induced non-alcoholic fatty liver disease rats. PLoS ONE, 29, e86724.

Li, Y., Xing, D., Chen, Q., & Chen, W. R. (2010). Enhancement of chemotherapeutic agentinduced apoptosis by inhibition of NF-κB using ursolic acid. International Journal of Cancer, 127, 462–473.

Lim, S. W., Hong, S. P., Jeong, S. W., Kim, B., Bak, H., Ryoo, H. C., Ahn, S. K. (2007). Simultaneous effect of ursolic acid and oleanolic acid on epidermal permeability barrier function and epidermal keratinocyte differentiation via peroxisome proliferator- activated receptor-α. Journal of Dermatology, 34(9), 625–634.

Liu, J. (1995). Pharmacology of oleanolic acid and ursolic acid. Journal of Ethnopharmacology, 49, 57–68.

Liu, J. (2005). Oleanolic acid and ursolic acid: Research perspectives. Journal of Ethnopharmacology, 100(1–2), 92–94.

Liu, J., Liu, Y., Mao, Q., & Klaassen, C. D. (1994). The effects of 10 triterpenoid compounds on experimental liver injury in mice. Fundamental and Applied Toxicology, 22(1), 34–40.

Lu, J., Zheng, Y. L., Wu, D. M., Luo, L., Sun, D. X., & Shan, Q. (2007). Ursolic acid ameliorates cognition deficits and attenuates oxidative damage in the brain of senescent mice induced by D-galactose. Biochemical Pharmacology, 74, 1078–1090.

Lv, Y., Tahir, I. I., & Olsson, M. E. (2016). Factors affecting the content of the ursolic and oleanolic acid in apple peel: Influence of cultivars, sun exposure, storage conditions, bruising and Penicillium expansum infection. Journal of the Science of Food and Agriculture, 96(6), 2161–2169.

M. Chen, X. Wang, B. Hu et al., “Ursolic acid stimulates UCP2 expression and protects H9c2 cells from hypoxiareoxygenation injury via p38 signaling,” Journal of Biosciences, vol. 43, no. 5, pp. 857–865, 2018.

M. Xiang, J. Wang, Y. Zhang, J. Ling, and X. Xu, “Attenuation of aortic injury by ursolic acid through RAGE-Nox-NF-κB pathway in streptozocin-induced diabetic rats,” Archives of Pharmacal Research, vol. 35, no. 5, pp. 877–886, 2012.

M. Zhai, J. Guo, H. Ma et al., “Ursolic acid prevents angiotensin II-induced abdominal aortic aneurysm in apolipoprotein E-knockout mice,” Atherosclerosis, vol. 271, pp. 128–135, 2018.

Ma, C. M., Cai, S. Q., Cui, J. R., Wang, R. Q., Tu, P. F., Hattori, M., & Daneshtalab, M. (2005). The cytotoxic activity of ursolic acid derivatives. European Journal of Medicinal Chemistry, 40, 582–589.

Mallavadhani, U. V., Mahapatra, A., Pattnaik, B., Vanga, N., Suri, N., & Saxena, A. K. (2013). Synthesis and anti-cancer activity of some novel C-17 analogs of ursolic and oleanolic acids. Medical Chemistry Research, 22, 1263–1269.

Navina, R., Lee, Y. G., & Kim, S. M. (2017). Molecular biological roles of ursolic acid in the treatment of human diseases. Current Bioactive Compounds, 13(3), 177–185.

Novotny, L., Vachalkova, A., & Biggs, D. (2001). Ursolic acid: An anti-tumorigenic and chemopreventive activity. Neoplasma, 48(4), 241–246.

Ovesna, Z., Vachalkova, A., Horvathova, K., & Tothova, D. (2004). Pentacyclic triterpenoic acids: New chemoprotective compounds. Neoplasma, 51(5), 327–333.

Pensec, F., Paczkowski, C., Grabarczyk, M., Wozniak, A., Benard-Gellon, M., Bertsch, C., Szakiel, A. (2014). Changes in the triterpenoid content of cuticular waxes during fruit ripening of eight grape (Vitis vinifera) cultivars grown in the Upper Rhine valley. Journal of Agricultural and Food Chemistry, 62(32), 7998–8007.

Peragón, J. (2013). Time course of pentacyclic triterpenoids from fruits and leaves of olive tree (Olea europaea L.) cv. Picual and cv. Cornezuelo during ripening. Journal of Agricultural and Food Chemistry, 61(27), 6671–6678.

Pozo, M., Castilla, V., Gutiérrez, C., de Nicolás, R., Egido, J., & González-Cabrero, J. (2006). Ursolic acid inhibits neointima formation in the rat carotid artery injury model. Atherosclerosis, 184, 53–62.

Q. Li, W. Zhao, X. Zeng, and Z. Hao, “Ursolic acid attenuates atherosclerosis in ApoE−/− mice: role of LOX-1 mediated by ROS/NF-κB pathway,” Molecules, vol. 23, no. 5, p. 1101, 2018.

R. A. Bhat, M. C. Lingaraju, N. N. Pathak et al., “Effect of ursolic acid in attenuating chronic constriction injuryinduced neuropathic pain in rats,” Fundamental & Clinical Pharmacology, vol. 30, no. 6, pp. 517–528, 2016.

R. Saravanan and V. Pugalendi, “Impact of ursolic acid on chronic ethanol-induced oxidative stress in the rat heart,” Pharmacological Reports, vol. 58, no. 1, pp. 41–47, 2006.

R. Saravanan, P. Viswanathan, and K. V. Pugalendi, “Protective effect of ursolic acid on ethanol-mediated experimental liver damage in rats,” Life Sciences, vol. 78, no. 7, pp. 713– 718, 2006.

R. Yin, T. Li, J. X. Tian, P. Xi, and R. H. Liu, “Ursolic acid, a potential anticancer compound for breast cancer therapy,” Critical Reviews in Food Science and Nutrition, vol. 58, no. 4, pp. 568–574, 2018.

Ramos, A. A., Pereira-Wilson, C., & Collins, A. R. (2010). Protective effects of ursolic acid and luteolin against oxidative DNA damage include enhancement of DNA repair in Caco-2 cells. Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 692, 6–11.

Raphael, T. J., & Kuttan, G. (2003). Effect of naturally occurring triterpenoids glycyrrhizic acid, ursolic acid, oleanolic acid and nomilin on the immune system. Phytomedicine, 10(6–7), 483–489.

Raphael, T. J., & Kuttan, G. (2008). Effect of naturally occurring triterpenoids ursolic acid and glycyrrhizic acid on the cell-mediated immune responses of metastatic tumorbearing animals. Immunopharmacology and Immunotoxicology, 30(2), 243–255.

Razborsek, M. I., Voncina, D. B., Dolecek, V., & Voncina, E. (2008). Determination of oleanolic, betulinic and ursolic acid in Lamiaceae and mass spectral fragmentation of their trimethylsilylated derivatives. Chromatographia, 67(5–6), 433–440.

Recio, M. C., Giner, R. M., Manez, S., & Ríos, J. L. (1995). Structural requiriments for the anti-inflammatory activity of natural triterpenoids. Planta Médica, 61(2), 182–185.

Rodrigues, I. A., Mazotto, A. M., Cardoso, V., Alves, R. L., Amaral, A. C. F., Silva, J. R. D. A., Vermelho, A. B. (2015). Natural products: Insights into Leishmaniasis inflammatory response. Mediators of Inflammation (Article number 835910).

S. E. Jang, J. J. Jeong, S. R. Hyam, M. J. Han, and D. H. Kim, “Ursolic acid isolated from the seed of Cornus officinalis ameliorates colitis in mice by inhibiting the binding of lipopolysaccharide to Toll-like receptor 4 on macrophages,” Journal of Agricultural and Food Chemistry, vol. 62, no. 40, pp. 9711–9721, 2014.

S. H. Kim, J. H. Hong, and Y. C. Lee, “Ursolic acid, a potential PPARγ agonist, suppresses ovalbumin-induced airway inflammation and Penh by down-regulating IL-5, IL-13, and IL-17 in a mouse model of allergic asthma,” European Journal of Pharmacology, vol. 701, no. 1-3, pp. 131–143, 2013.

S. Habtemariam, “Going back to the good old days: the merit of crude plant drug mixtures in the 21st century,” International Journal of Complementary & Alternative Medicine, vol. 6, no. 2, article 00182, 2017.

S. Habtemariam, “Iridoids and other monoterpenes in the Alzheimer’s brain: recent development and future prospects,” Molecules, vol. 23, no. 1, p. 117, 2018.

S. Habtemariam, “Protective effects of caffeic acid and the Alzheimer’s brain: an update,” Mini-Reviews in Medicinal Chemistry, vol. 17, no. 8, pp. 667–674, 2017.

S. Habtemariam, “Rutin as a natural therapy for Alzheimer’s disease: insights into its mechanisms of action,” Current Medicinal Chemistry, vol. 23, no. 9, pp. 860–873, 2016.

S. Habtemariam, “The brain-derived neurotrophic factor in neuronal plasticity and neuroregeneration: new pharmacological concepts for old and new drugs,” Neural Regeneration Research, vol. 13, no. 6, pp. 983-984, 2018.

S. Habtemariam, “The therapeutic potential of rosemary (Rosmarinus officinalis) diterpenes for Alzheimer’s disease,” Evidence-Based Complementary and Alternative Medicine, vol. 2016, Article ID 2680409, 14 pages, 2016.

S. L. Ullevig, Q. Zhao, D. Zamora, and R. Asmis, “Ursolic acid protects diabetic mice against monocyte dysfunction and accelerated atherosclerosis,” Atherosclerosis, vol. 219, no. 2, pp. 409–416, 2011.

S. Leng, S. Iwanowycz, F. Saaoud et al., “Ursolic acid enhances macrophage autophagy and attenuates atherogenesis,” Journal of Lipid Research, vol. 57, no. 6, pp. 1006–1016, 2016.

S. Li, F. Meng, X. Liao et al., “Therapeutic role of ursolic acid on ameliorating hepatic steatosis and improving metabolic disorders in high-fat diet-induced non-alcoholic fatty liver disease rats,” PLoS One, vol. 9, no. 1, article e86724, 2014.

S. Y. Baek, J. Lee, D. G. Lee et al., “Ursolic acid ameliorates autoimmune arthritis via suppression of Th17 and B cell differentiation,” Acta Pharmacologica Sinica, vol. 35, no. 9, pp. 1177–1187, 2014.

S. Y. Kang, S. Y. Yoon, D. H. Roh et al., “The anti-arthritic effect of ursolic acid on zymosan-induced acute inflammation and adjuvant-induced chronic arthritis models,” Journal of Pharmacy and Pharmacology, vol. 60, no. 10, pp. 1347– 1354, 2008.

Safayhi, H., & Sailer, E. R. (1997). Anti-inflammatory actions of pentacyclic triterpenes. Planta Médica, 63(6), 487–493. Salvador, T. C., Rocha, S. M., & Silvestre, A. J. D. (2015). Lipophilic phytochemicals from elderberries (Sambucus nigra L.): Influence of ripening, cultivar and season. Industrial Crops and Products, 71, 15–23.

Saravanan, R., Viswanathan, P., & Pugalendi, K. V. (2006). Protective effect of ursolic acid on ethanol-mediated experimental liver damage in rats. Life Sciences, 78, 713–718.

Sehrawat A, Roy R, Pore SK, Hahm ER, Samanta SK, Singh KB, Kim SH, Singh K, Singh SV. Mitochondrial dysfunction in cancer chemoprevention by phytochemicals from dietary and medicinal plants. Semin Cancer Biol. 2017;47:147-153.

Shanmugam, M. K., Dai, X., Kumar, A. P., Tan, B. K. H., Sethi, G., & Bishayee, A. (2013). Ursolic acid in cancer prevention and treatment: Molecular targets, pharmacokinetics and clinical studies. Biochemical Pharmacology, 85, 1579–1587.

Shanmugam, M. K., Ong, T. H., Kumar, A. P., Lun, C. K., Ho, P. C., Wong, P. T., Sethi, G. (2012). Ursolic acid inhibits the initiation, progression of prostate cancer and prolongs the survival of TRAMP mice by modulating pro-inflammatory pathways. PLoS ONE, 7, e32476.

Shyu, M. H., Kao, T. C., & Yen, G. C. (2010). Oleanolic acid and ursolic acid induce apoptosis in HuH7 human hepatocellular carcinoma cells through a mitochondrialdependent pathway and downregulation of XIAP. Journal of Agricultural and Food Chemistry, 58(10), 6110–6118.

Silva, F. S. G., Oliveira, P. J., & Duarte, M. F. (2016). Oleanolic, ursolic, and betulinic acids as food supplements or pharmaceutical agents for type 2 diabetes: Promise or Illusion? Journal of Agricultural and Food Chemistry, 64, 2991–3008.

Silva, M. G. V., Vieira, I. G. P., Mendes, F. N. P., Albuquerque, I. L., dos Santos, R. N., Silva, F. O., & Morais, S. M. (2008). Variation of ursolic acid content in eight Ocimum species from Northeastern Brazil. Molecules, 13(10), 2482–2487.

Soica, C., Oprean, C., Borcan, F., Danciu, C., Trandafirescu, C., Coricovac, D., Munteanu, M. (2014). The synergistic biologic activity of oleanolic and ursolic acids in complex with hydroxypropyl-gamma-cyclodextrin. Molecules, 19(4), 4924–4940. Somova, L. I., Shode, F. O., & Mipando, M. (2004). Cardiotonic and antidysrhythmic effects of oleanolic and ursolic acids, methyl maslinate and uvaol. Phytomedicine, 11, 121–129.

Somova, L. O., Nadar, A., Rammanan, P., & Shode, F. O. (2003). Cardiovascular, antihyperlipidemic and antioxidant effects of oleanolic and ursolic acids in experimental hypertension. Phytomedicine, 10, 115–121.

Song, J., Wang, Y., Song, Y., Chan, H., Bi, C., Yang, X., Zheng, Y. (2014). Development and characterisation of ursolic acid nanocrystals without stabiliser having improved dissolution rate and in vitro anticancer activity. American Association of Pharmaceutical Scientists, 15(1), 11–19.

Suh, N., Honda, T., Finlay, H. J., Barchowsky, A., Williams, C., Benoit, N. E., Sporn, M. B. (1998). Novel triterpenoids suppress inducible nitric oxide synthase (iNOS) and inducible cyclooxygenase (COX-2) in mouse macrophages. Cancer Research, 58, 717–723.

Sultana, N. (2011). Clinically useful anticancer, antitumor, and antiwrinkle agent, ursolic acid and related derivatives as medicinally important natural product. Journal of Enzyme Inhibition and Medicinal Chemistry, 26(5), 616–642.

Szakiel, A., & Mroczek, A. (2007). Distribution of triterpene acids and their derivatives in organs of cowberry (Vaccinium vitis-idaea L.) plant. Acta Biochimica Polonica, 54(4), 733–740.

Szakiel, A., Pa̧czkowski, C., Pensec, F., & Bertsch, C. (2012). Fruit cuticular waxes as a source of biologically active triterpenoids. Phytochemistry Reviews, 11(2–3), 263–284.

T. O. Elufioye, T. I. Berida, and S. Habtemariam, “Plantsderived neuroprotective agents: cutting the cycle of cell death through multiple mechanisms,” Evidence-Based Complementary and Alternative Medicine, vol. 2017, Article ID 3574012, 27 pages, 2017.

Takada, K., Nakane, T., Masuda, K., & Ishii, H. (2010). Ursolic acid and oleanolic acid, members of pentacyclic triterpenoid acids, suppress TNF-α-induced E-selectin expression by cultured umbilical vein endothelial cells. Phytomedicine, 17(14), 1114–1119.

Vagi, E., Simandi, B., Daood, H. G., Deak, A., & Sawinsky, J. (2002). Recovery of pigments from Origanum majorana L. by extraction with supercritical carbon dioxide. Journal of Agricultural and Food Chemistry, 50, 2297–2301.

W. Zhou, L. Lin, Y. Cheng, and Y. Liu, “Ursolic acid improves liver transplantation and inhibits apoptosis in miniature pigs using donation after cardiac death,” Cellular Physiology and Biochemistry, vol. 43, no. 1, pp. 331–338, 2017.

Wang, Y. L., Wang, Z. J., Shen, H. L., Yin, M., & Tang, K. X. (2013). Effects of artesunate and ursolic acid on hyperlipidemia and its complications in rabbit. European Journal of Pharmaceutical Sciences, 50(3–4), 366–371.

Wang, Y., Wang, Z., Shen, H., Yin, M., & Tang, K. (2015). The hypolipidemic effect of artesunate and ursolic acid in rats. Pakistan Journal of Pharmaceutical Sciences, 28(3), 871–874.

Wójciak-Kosior, M., Paduch, R., Matysik-Woźniak, A., Niedziela, P., & Donica, H. (2011). The effect of ursolic and oleanolic acids on human skin fibroblast cells. Folia Histochemica et Cytobiologica, 49(4), 664–669.

Wozniak l, Skąpska S, Marszałek K. Ursolic acid a pentacyclic triterpenoid with a wide spectrum of pharmacological activities. Molecules . 2015;20:20614-20641.

Woźniak, L., Skąpska, S., & Marszałek, K. (2015). Ursolic acid - A pentacyclic triterpenoid with a wide spectrum of pharmacological activities. Molecules, 20(11), 20,614–20,641.

Wu, P., He, P., Huang, T., Lu, Y., & Zhang, K. (2014). Effects of ursolic acid derivatives on Caco-2 cells and their alleviating role in streptozocin-induced type 2 diabetic rats. Molecules, 19(8), 12,559–12,576.

X. Chen, Y. Wan, T. Zhou, J. Li, and Y. Wei, “Ursolic acid attenuates lipopolysaccharide-induced acute lung injury in a mouse model,” Immunotherapy, vol. 5, no. 1, pp. 39–47, 2013.

X. Ma, Y. Zhang, Z. Wang et al., “Ursolic acid, a natural nutraceutical agent, targets caspase3 and alleviates inflammation‐ associated downstream signal transduction,” Molecular Nutrition & Food Research, vol. 61, no. 12, 2017.

X. T. Wang, Y. Gong, B. Zhou et al., “Ursolic acid ameliorates oxidative stress, inflammation and fibrosis in diabetic cardiomyopathy rats,” Biomedicine & Pharmacotherapy, vol. 97, pp. 1461–1467, 2018.

Xing, Y. L., Bi, L. W., Zhao, Z. D., & Xia, T. J. (2013). Simultaneous determination of oleanolic acid and ursolic acid in leaves of paulownia by HPLC. Advanced Materials Research, 781–784, 787–791.

Y. L. Wang, Z. J. Wang, H. L. Shen, M. Yin, and K. X. Tang, “Effects of artesunate and ursolic acid on hyperlipidemia and its complications in rabbit,” European Journal of Pharmaceutical Sciences, vol. 50, no. 3-4, pp. 366–371, 2013.

Y. Yang, Z. Zhao, Y. Liu, X. Kang, H. Zhang, and M. Meng, “Suppression of oxidative stress and improvement of liver functions in mice by ursolic acid via LKB1‐AMP‐activated protein kinase signaling,” Journal of Gastroenterology and Hepatology, vol. 30, no. 3, pp. 609–618, 2015.

Y. Zhang, C. Song, H. Li, J. Hou, and D. Li, “Ursolic acid prevents augmented peripheral inflammation and inflammatory hyperalgesia in high-fat diet-induced obese rats by restoring downregulated spinal PPARα,” Molecular Medicine Reports, vol. 13, no. 6, pp. 5309–5316, 2016.

Yamaguchi, H., Noshita, T., Kidachi, Y., Umetsu, H., Hayashi, M., Komiyama, K., Royayama, K. (2008). Isolation of ursolic acid from apple peels and its specific efficacy as a potent antitumor agent. Journal of Health Science, 54(6), 654–660.

Yarosh, D. B., Both, D., & Brown, D. (2000). Liposomal ursolic acid (merotaine) increases ceramides and collagen in human skin. Hormone Research, 54(5–6), 318–321.

You, H. J., Cho, C. Y., Kim, J. Y., Park, S. J., Hahm, K. S., & Jeong, H. G. (2001). Ursolic acid enhances nitric oxide and tumor necrosis factor-α production via nuclear factor- κB activation in the resting macrophages. FEBS Letters, 509, 156–160.

Z. Hu, Z. Gu, M. Sun et al., “Ursolic acid improves survival and attenuates lung injury in septic rats induced by cecal ligation and puncture,” Journal of Surgical Research, vol. 194, no. 2, pp. 528–536, 2015.

Z. Zhang, H. Zhang, R. Chen, and Z. Wang, “Oral supplementation with ursolic acid ameliorates sepsis-induced acute kidney injury in a mouse model by inhibiting oxidative stress and inflammatory responses,” Molecular Medicine Reports, vol. 17, no. 5, pp. 7142–7148, 2018.

Zaletova, N. I., Shchavlinskii, A. N., Tolkachev, O. N., Vichkanova, S. A., Fateeva, T. V., Krutikova, N. M., Klyuev, N. A. (1986). Preparation of certain derivatives of ursolic acid and their antimicrobial activity. Pharmaceutical Chemistry Journal, 20(5), 345–348.

Zhang, F., Daimaru, E., Ohnishi, M., Kinoshita, M., & Tokuji, Y. (2013). Oleanolic acid and ursolic acid in commercial dried fruits. Food Science and Technology Research, 19(1), 113–116.

Zhang, H., Li, X., Ding, J., Xu, H., Dai, X., Hou, Z., Weihao, S. (2013). Delivery of ursolic acid (UA) in polymeric nanoparticles effectively promotes the apoptosis of gastric cancer cells through enhanced inhibition of cyclooxygenase 2 (COX-2). International Journal of Pharmaceutics, 441(1–2), 261–268.

Zhang, Y., Si, Y., Zhai, L., Guo, S., Zhao, J., Sang, H., Qin, S. (2016). Celastrus orbiculatus Thunb. reduces lipid accumulation by promoting reverse cholesterol transport in hyperlipidemic mice. Lipids, 51, 677–692.

Statistics
200 Views | 158 Downloads
Dimension Citations

Published

27-12-2019

How to Cite

Bharat Vashistha, and Manish Jaimini. “A REVIEW OF THE PHARMACOLOGICAL PROPERTIES OF URSOLIC ACID”. Tropical Journal of Pharmaceutical and Life Sciences, vol. 6, no. 6, Dec. 2019, pp. 01-19, doi:10.61280/tjpls.v6i6.112.

Issue

Section

Review Article